Although Calphostin C and resveratrol have been reported to inhibit ATAD3A expression in lung cancer cells [18,61], these approaches do not directly inhibit ATAD3A; in fact, no specific inhibitors targeting ATAD3A are currently available. This evidence concerns the gene ATAD3A and lung carcinoma.